Laboratorios Pablo Cassará

Laboratorios Pablo Cassará is a leading Argentine pharmaceutical company founded in 1948, specializing in the development, manufacturing, and commercialization of high-quality therapeutic products. The company is a regional pioneer in respiratory health, particularly known for its advanced inhalation technologies including metered-dose inhalers and dry powder inhalers for asthma and COPD. In recent years, Cassará has significantly expanded its biotechnology capabilities, notably co-developing the ARVAC Cecilia Grierson vaccine, Argentina's first domestically produced COVID-19 vaccine. Operating multiple GMP-certified facilities, the company maintains a strong commitment to research and development through strategic alliances with national scientific institutions like CONICET and UNSAM.